Q2 26 EPS
$2.45
BEAT +10.21%
Est. $2.22
Q2 26 Revenue
$2.75B
MISS 0.89%
Est. $2.78B
vs S&P Since Q2 26
-1.2%
TRAILING MARKET
CE -0.2% vs S&P +1.0%
Market Reaction
Did CE Beat Earnings? Q2 2026 Results
Celanese Corp posted a stronger-than-expected second quarter, with adjusted EPS of $2.45 beating the $2.23 consensus estimate by 10.21%, even as revenue of $2.75 billion fell just shy of the $2.78 billion analyst forecast, a -0.89% miss that belied a… Read more Celanese Corp posted a stronger-than-expected second quarter, with adjusted EPS of $2.45 beating the $2.23 consensus estimate by 10.21%, even as revenue of $2.75 billion fell just shy of the $2.78 billion analyst forecast, a -0.89% miss that belied an 8.7% year-over-year revenue gain. The standout driver was a sharp inflection in the Acetyl Chain segment, which surged 28% sequentially on 22% pricing gains as Celanese leveraged its integrated global network to capture supply-related opportunities in the Western Hemisphere, helping lift operating EBITDA to $649.00 million at a 24% margin. The quarter's momentum was substantial enough that analysts broadly maintain a buy-leaning stance on the stock, though the company itself expects moderation ahead; Q3 2026 adjusted EPS guidance of $1.35 to $1.75 reflects anticipated easing of those supply tailwinds, higher raw material costs, and inventory-related charges from ongoing footprint optimization. Full-year 2026 guidance holds at approximately $6.00 adjusted EPS and $700 to $800 million in free cash flow, with deleveraging remaining a clear strategic priority as net debt declined to $10.64 billion.
Key Takeaways
- • Strong pricing execution across both segments, particularly 22% sequential price increase in Acetyl Chain
- • Favorable mix in Engineered Materials driven by medical and electronics platforms
- • Leveraging integrated global manufacturing and supply chain network to capture supply-related opportunities
- • Successful rapid restart of Frankfurt VAM unit
CE Forward Guidance & Outlook
Celanese expects Q3 2026 adjusted EPS of approximately $1.35 to $1.75, reflecting moderation of supply-related opportunities, higher raw material costs in Engineered Materials, and inventory-related actions from nylon 6,6 and Lanaken footprint optimizations. Full-year 2026 guidance is maintained at approximately $6.00 adjusted EPS and $700–$800 million of free cash flow. The company expects its adjusted tax rate of 8% to hold for full-year 2026.
CE YoY Financials
Q2 2026 vs Q2 2025, source: SEC Filings
CE Revenue by Segment
With YoY comparisons, source: SEC Filings
“The second quarter demonstrated the agility and focus of Celanese and the benefits of the actions we are taking across both businesses.”
— Scott Richardson, Q2 2026 Earnings Press Release
CE Earnings Trends
CE vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
CE EPS Trend
Earnings per share: estimate vs actual
CE Revenue Trend
Quarterly revenue: estimate vs actual
CE Quarterly Results
6 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q2 26 BEAT | $2.22 | $2.45 | +10.21% | $2.75B | -0.89% |
| Q1 26 MISS | $0.88 | $0.85 | -3.61% | $2.34B | -0.41% |
| Q4 25 MISS FY | $0.91 | $0.67 | -26.37% | $2.20B | -2.02% |
| FY Full Year | $4.25 | $3.98 | -6.42% | $9.54B | -0.41% |
| Q3 25 BEAT | $1.22 | $1.34 | +9.59% | $2.42B | -3.71% |
| Q2 25 BEAT | $1.40 | $1.44 | +2.82% | $2.53B | +1.89% |
| Q1 25 BEAT | $0.39 | $0.57 | +47.82% | $2.39B | +5.54% |